Recommendations for Post-Operative Radiotherapy after complete resection of Thymoma - a French DELPHI consensus initiative.
Fiche publication
Date publication
avril 2024
Journal
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Dr MARTIN Etienne, Dr FAIVRE Jean-Christophe
Tous les auteurs :
Basse C, Khalifa J, Thillays F, Le Pechoux C, Maury JM, Bonte PE, Coutte A, Pourel N, Bourbonne V, Pradier O, Belliere A, Le Tinier F, Deberne M, Tanguy R, Denis F, Padovani L, Zaccariotto A, Molina T, Chalabreysse L, Brioude G, Delatour B, Faivre JC, Cao K, Giraud P, Riet FG, Thureau S, Antoni D, Massabeau C, Keller A, Bonnet E, Lerouge D, Martin E, Girard N, Botticella A
Lien Pubmed
Résumé
Thymomas are rare intrathoracic malignancies that can relapse after surgery. Whether or not Post-Operative Radiotherapy (PORT) should be delivered after surgery remains a major issue. RADIORYTHMIC is an ongoing, multicenter, randomized phase 3 trial addressing this question in patients with completely R0 resected Masaoka-Koga stage IIb/III thymoma. Experts in the field met to develop recommendations for PORT.
Mots clés
DELPHI, Intensity-Modulated Radiation Therapy (IMRT), Post-Operative Radiotherapy, Recommendations, Thymoma
Référence
J Thorac Oncol. 2024 04 10;: